期刊
CHEMMEDCHEM
卷 17, 期 18, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202200345
关键词
human topoisomerases; actin; silver N-heterocyclic carbine complexes; breast cancer; docking studies
资金
- Italian Ministry of Health
- MUR, Italy [2017M8R7N9_004, 2020KSY3KL_005]
- Area di Specializzazione Salute [ARS01_00568]
- Universita della Calabria within the CRUI-CARE Agreement
A new series of silver N-heterocyclic carbene complexes were designed and synthesized, showing anticancer activity against breast cancer cells as well as antimicrobial activity. The multiple target actions of these complexes provide an interesting direction for the development of new chemotherapeutic agents.
In recent years, the number of people suffering from cancer has risen rapidly and the World Health Organization and U.S. and European governments have identified this pathology as a priority issue. It is known that most bioactive anticancer molecules do not target a single protein but exert pleiotropic effects, simultaneously affecting multiple pathways. In our study, we designed and synthesized a new series of silver N-heterocyclic carbene (NHC) complexes [(NHC)(2)Ag](+)[AgX2](-) (X=iodide or acetate). The new complexes were active against two human breast cancer cell lines, MCF-7 and MDA-MB-231. These compounds showed multiple target actions as anticancer, by inhibiting in vitro the activity of the human topoisomerases I and II and interfering with the cytoskeleton dynamic, as also confirmed by in silico studies. Moreover, the antimicrobial activity of these silver complexes was studied against Gram-positive/negative bacteria. These dual properties provide a two-tiered approach, making these compounds of interest to be further deepened for the development of new chemotherapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据